Contraceptive Device Discovered to Have Broad Spectrum Application for Women’s Basic Unmet Needs

{"title":"Contraceptive Device Discovered to Have Broad Spectrum Application for Women’s Basic Unmet Needs","authors":"","doi":"10.33140/jgrm.05.02.16","DOIUrl":null,"url":null,"abstract":"Introduction: The FemCap is an FDA, and CE mark approved barrier contraceptive device. To our surprise, it was found to apply to several basic unmet reproductive health needs for women. a) The FemCap is time tested hormone-free contraceptive device, b) It offers an alternative delivery system to the traditional vaginal applicator, c) It provides a safe and effective non-surgical treatment for stress urinary incontinence (SUI), d) It enhances the fertility awareness methods. Methodology: We conducted several pilot studies to explore the potential of the FemCap. We compared the retention and distribution of stained vaginal gel if inserted with the FemCap versus the same amount of gel when inserted by the vaginal applicator. We compared the safety and effectiveness of the FemCap with a vaginal pessary that treats stress urinary incontinence. We collected the fertile cervical mucous (Spinnbarkeit) with the FemCap to determine the time of ovulation to enhance the fertility awareness method. Results: The FemCap is a well-established, safe, and effective non-hormonal contraceptive. The retention and distribution of stained vaginal gel inserted with the FemCap is more efficient than the vaginal applicator. The FemCap’s unique storage groove for microbicides can potentially be utilized to treat sexually transmitted infections (STIs) topically. FemCap is also found to be substantially equivalent to the incontinence pessary in controlling stress urinary incontinence (SUI). The FemCap did also help to collect fertile cervical mucous (Spinnbarkeit) when using fertility awareness methods. Conclusion: The multipurpose FemCap would be an ideal tool for nurse practitioners, midwives, and physicians to provide women with safe and effective, hormone-free contraception. It also provides an efficient delivery system for spermicide/microbicides. It is much safer for non-surgical management of stress urinary incontinence. It is useful for the enhancement of fertility awareness methods. It is non-invasive and can be inserted and removed by the woman without professional help.","PeriodicalId":93778,"journal":{"name":"Journal of gynecology, clinical obstetrics and reproductive medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of gynecology, clinical obstetrics and reproductive medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33140/jgrm.05.02.16","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The FemCap is an FDA, and CE mark approved barrier contraceptive device. To our surprise, it was found to apply to several basic unmet reproductive health needs for women. a) The FemCap is time tested hormone-free contraceptive device, b) It offers an alternative delivery system to the traditional vaginal applicator, c) It provides a safe and effective non-surgical treatment for stress urinary incontinence (SUI), d) It enhances the fertility awareness methods. Methodology: We conducted several pilot studies to explore the potential of the FemCap. We compared the retention and distribution of stained vaginal gel if inserted with the FemCap versus the same amount of gel when inserted by the vaginal applicator. We compared the safety and effectiveness of the FemCap with a vaginal pessary that treats stress urinary incontinence. We collected the fertile cervical mucous (Spinnbarkeit) with the FemCap to determine the time of ovulation to enhance the fertility awareness method. Results: The FemCap is a well-established, safe, and effective non-hormonal contraceptive. The retention and distribution of stained vaginal gel inserted with the FemCap is more efficient than the vaginal applicator. The FemCap’s unique storage groove for microbicides can potentially be utilized to treat sexually transmitted infections (STIs) topically. FemCap is also found to be substantially equivalent to the incontinence pessary in controlling stress urinary incontinence (SUI). The FemCap did also help to collect fertile cervical mucous (Spinnbarkeit) when using fertility awareness methods. Conclusion: The multipurpose FemCap would be an ideal tool for nurse practitioners, midwives, and physicians to provide women with safe and effective, hormone-free contraception. It also provides an efficient delivery system for spermicide/microbicides. It is much safer for non-surgical management of stress urinary incontinence. It is useful for the enhancement of fertility awareness methods. It is non-invasive and can be inserted and removed by the woman without professional help.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
发现避孕器具广泛适用于妇女的基本需求
简介:FemCap是FDA和CE认证的屏障避孕装置。令我们惊讶的是,它适用于妇女未得到满足的几项基本生殖健康需求。a) FemCap是一种经过时间考验的无激素避孕装置,b)它为传统的阴道涂药器提供了另一种输送系统,c)它为压力性尿失禁(SUI)提供了一种安全有效的非手术治疗方法,d)它提高了生育意识方法。方法:我们进行了一些试点研究探索FemCap的潜力。我们比较了用FemCap插入染色阴道凝胶与用阴道涂抹器插入相同数量凝胶的保留和分布情况。我们比较了FemCap与阴道托治疗压力性尿失禁的安全性和有效性。采用FemCap采集可育宫颈粘液(Spinnbarkeit)测定排卵时间,提高受孕意识的方法。结果:FemCap是一种成熟、安全、有效的非激素避孕药。用FemCap插入染色阴道凝胶的保留和分布比阴道涂抹器更有效。FemCap独特的杀微生物剂储存槽可以潜在地用于局部治疗性传播感染(sti)。FemCap也被发现基本上等同于控制压力性尿失禁(SUI)所必需的失禁。当使用生育意识方法时,FemCap也有助于收集可育宫颈粘液(Spinnbarkeit)。结论:多功能FemCap将是护士、助产士和医生为妇女提供安全、有效、无激素避孕的理想工具。它还为杀精剂/杀微生物剂提供了一个有效的输送系统。是更安全的非手术治疗压力性尿失禁。这对提高生育意识的方法是有益的。非侵入性,可以插入和删除的女人没有专业的帮助。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Delayed Presentation of Herlyn-Werner-Wunderlich Syndrome; A Rare Congenital Anomaly: A Case Report and literature Review Prevalence and Determinants of Intimate Partner Violence Against Women in Burundi: Evidence from 2016-17 Demographic and Health Survey Quick Sequential Organ Failure Assessment Score in Recognizing Infected Patients with Organ Dysfunction & Prediction of Mortality: Cohort Study Prenatal Diagnosis and Follow-Up of Fetal Cardiac Tumors Association of Pharmacy Services with Patient Satisfaction in Public and Private Tertiary Care Hospitals of Rawalpindi And Islamabad
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1